SCHEMBL29469844

SCHEMBL29469844

Cc1ccc(S(=O)(=O)Cl)c2ccncc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
CSNK1E P49674 1/20 0.38
CSNK1G2 P78368 1/20 0.38
CSNK1G1 Q9HCP0 1/20 0.38
SLC22A12 Q96S37 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NR2F2 P24468 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HTR6 P50406 1/20 0.35
TRPV4 Q9HBA0 1/20 0.34
CA12 O43570 5/20 0.33
CA1 P00915 5/20 0.33
CA2 P00918 5/20 0.33
CA9 Q16790 5/20 0.33
CA14 Q9ULX7 2/20 0.33
ALPL P05186 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
HIPK2 Q9H2X6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1491302 0.83 POLB (0.38) CSNK1A1CSNK1DCSNK1ECSNK1G2CSNK1G1
SCHEMBL2871943 0.79 CA12 (0.47) ALDH1A1L3MBTL1TRPV4CA12CA1
SCHEMBL812489 0.77 CYP1A2 (0.46) SLC22A12ALDH1A1HIPK2TDP1KMT2A
SCHEMBL17709907 0.76 AXL (0.51) CSNK1A1CSNK1DCSNK1ECSNK1G2CSNK1G1
SCHEMBL640546 0.76 CYP1A2 (0.54) SLC22A12ALDH1A1HTR6TRPV4TDP1
SCHEMBL27143147 0.76 CA12 (0.38) ALDH1A1CA12CA1CA2CA9
SCHEMBL1828055 0.76 CA12 (0.42) ALDH1A1CA12CA1CA2CA9
SCHEMBL289039 0.72 GAA (0.43) CSNK1A1CSNK1DCSNK1ECSNK1G2CSNK1G1
SCHEMBL16261223 0.71 CSNK1A1 (0.43) CSNK1A1CSNK1DCSNK1ECSNK1G2CSNK1G1
SCHEMBL115053 0.70 CYP3A4 (0.56) KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed